M. Likmeta, A. Shkoza, L. Zguri, and B. Kraja, “CHRONIC HEPATITIS C WITH SIGNIFICANT MORBIDITY AND END-ORGAN DAMAGE DEVELOPMENT DURING PEG-INTERFERON ALPHA-2A/RIBAVIRIN THERAPY”, ESJ, vol. 11, no. 18, Jun. 2015.